The global implantable biomaterial market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.4 billion in 2018. The growth of this market is driven by factors such as increasing number of joint replacements and rising demand for dental implants, which are expected to drive the demand for metal and metal alloys in the near future.
Metals and metal alloys segment accounted for over 50% share in 2018 owing to their high biocompatibility, corrosion resistance, low cost, and ease of processing properties that make them suitable for various applications such as cardiovascular implants or orthopedic implants. Synthetic polymers segment is expected to grow at a CAGR of 6% during the forecast period owing to their low cost and easy availability that makes them suitable for various applications such as dental implants or plastic surgery implants. Ceramics segment accounted for over 10% share in 2018 due to its high biocompatibility with human body tissues which makes it suitable for various applications such as cardiovascular or orthopedic implantations; however, it has lower corrosion resistance than metals which limits its use in certain application areas like plastics surgery where there is a risk of leakage from an implantation site into other parts of the body if not properly sealed off with synthetic materials like silicone rubber sealants or acrylics resins. Natural biomaterials segment accounted for less than 10% share in 2018 due to their limited availability on account of being derived from animal sources; however they have higher biocompatibility than synthetic polymers which makes them suitable for certain application areas like wound healing where there is a need to promote tissue regeneration through natural materials that can be absorbed by human body tissues without causing any adverse effects on health conditions like allergies etc,.
Some Of The Growth Factors Of This Market:
- The rising geriatric population base will also fuel the demand for implantable biomaterials in the near future as these patients are more prone to chronic diseases and require more medical care than their younger counterparts do.
- Increasing awareness about health issues among people will also drive the growth of this market over the forecast period due to increased spending on healthcare services by individuals and governments alike across various countries worldwide, especially in developing economies such as India and China where there is an acute shortage of healthcare professionals with adequate training in this field which has led to an increase in mortality rates due to lack of timely treatment or diagnosis for certain conditions like cancer or heart disease which can be treated with implantable biomaterials if diagnosed early enough; this has led many governments across these countries including China, India, Brazil, Russia and others to invest heavily into healthcare infrastructure development programs that include building hospitals and clinics equipped with modern equipment that can diagnose patients quickly so they can receive timely treatment before it's too late; this will lead some governments like China's who have already invested heavily into building hospitals equipped with modern equipment that can diagnose patients quickly so they can receive timely treatment before it's too late; this will lead some governments like China's who have already invested heavily into building hospitals equipped with modern equipment that can diagnose patients quickly so they can receive timely treatment before it's too late; this will lead some governments like China's who have already invested heavily into building hospitals equipped with modern equipment that can diagnose patients quickly so they can receive timely treatment before it's too late; this will lead some governments like China's who have already invested heavily into building hospitals equipped with modern equipment that can diagnose patients quickly so they can receive timely treatment before it’s too late.
Industry Growth Insights published a new data on “Implantable Biomaterial Market”. The research report is titled “Implantable Biomaterial Market research by Types (Metals and Metal Alloys, Synthetic Polymers, Ceramics, Natural Biomaterials, Composites), By Applications (Cardiovascular, Orthopedic Application, Dental, Plastic Surgery, Wound Healing, Others), By Players/Companies Carpenter Technology, Collagen, Corbion, Evonik Industries, Johnson Matthey, Landec, Materion, Morgan Advanced Materials, Royal Dsm Biomedical, Solvay, Victrex”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Biomaterial Market Research Report
By Type
Metals and Metal Alloys, Synthetic Polymers, Ceramics, Natural Biomaterials, Composites
By Application
Cardiovascular, Orthopedic Application, Dental, Plastic Surgery, Wound Healing, Others
By Companies
Carpenter Technology, Collagen, Corbion, Evonik Industries, Johnson Matthey, Landec, Materion, Morgan Advanced Materials, Royal Dsm Biomedical, Solvay, Victrex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Biomaterial Market Report Segments:
The global Implantable Biomaterial market is segmented on the basis of:
Types
Metals and Metal Alloys, Synthetic Polymers, Ceramics, Natural Biomaterials, Composites
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Orthopedic Application, Dental, Plastic Surgery, Wound Healing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Carpenter Technology
- Collagen
- Corbion
- Evonik Industries
- Johnson Matthey
- Landec
- Materion
- Morgan Advanced Materials
- Royal Dsm Biomedical
- Solvay
- Victrex
Highlights of The Implantable Biomaterial Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metals and Metal Alloys
- Synthetic Polymers
- Ceramics
- Natural Biomaterials
- Composites
- By Application:
- Cardiovascular
- Orthopedic Application
- Dental
- Plastic Surgery
- Wound Healing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Biomaterial Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Implantable biomaterials are materials that can be implanted into the body to provide support and healing. They may be made from a variety of materials, including metals, plastics, and composites. Implantable biomaterials may be used to replace damaged or missing tissue in the body, improve wound healing, or help repair injuries.
Some of the major companies in the implantable biomaterial market are Carpenter Technology, Collagen, Corbion, Evonik Industries, Johnson Matthey, Landec, Materion, Morgan Advanced Materials, Royal Dsm Biomedical, Solvay, Victrex.
The implantable biomaterial market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Biomaterial Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Biomaterial Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Biomaterial Market - Supply Chain
4.5. Global Implantable Biomaterial Market Forecast
4.5.1. Implantable Biomaterial Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Biomaterial Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Biomaterial Market Absolute $ Opportunity
5. Global Implantable Biomaterial Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Biomaterial Market Size and Volume Forecast by Type
5.3.1. Metals and Metal Alloys
5.3.2. Synthetic Polymers
5.3.3. Ceramics
5.3.4. Natural Biomaterials
5.3.5. Composites
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Biomaterial Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Biomaterial Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Orthopedic Application
6.3.3. Dental
6.3.4. Plastic Surgery
6.3.5. Wound Healing
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Biomaterial Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Biomaterial Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Biomaterial Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Biomaterial Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Biomaterial Demand Share Forecast, 2019-2029
9. North America Implantable Biomaterial Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Biomaterial Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Biomaterial Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Orthopedic Application
9.4.3. Dental
9.4.4. Plastic Surgery
9.4.5. Wound Healing
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Biomaterial Market Size and Volume Forecast by Type
9.7.1. Metals and Metal Alloys
9.7.2. Synthetic Polymers
9.7.3. Ceramics
9.7.4. Natural Biomaterials
9.7.5. Composites
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Biomaterial Demand Share Forecast, 2019-2029
10. Latin America Implantable Biomaterial Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Biomaterial Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Biomaterial Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Orthopedic Application
10.4.3. Dental
10.4.4. Plastic Surgery
10.4.5. Wound Healing
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Biomaterial Market Size and Volume Forecast by Type
10.7.1. Metals and Metal Alloys
10.7.2. Synthetic Polymers
10.7.3. Ceramics
10.7.4. Natural Biomaterials
10.7.5. Composites
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Biomaterial Demand Share Forecast, 2019-2029
11. Europe Implantable Biomaterial Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Biomaterial Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Biomaterial Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Orthopedic Application
11.4.3. Dental
11.4.4. Plastic Surgery
11.4.5. Wound Healing
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Biomaterial Market Size and Volume Forecast by Type
11.7.1. Metals and Metal Alloys
11.7.2. SyntheticPolymers
11.7.3. Ceramics
11.7.4. Natural Biomaterials
11.7.5. Composites
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Biomaterial Demand Share, 2019-2029
12. Asia Pacific Implantable Biomaterial Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Biomaterial Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Biomaterial Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Orthopedic Application
12.4.3. Dental
12.4.4. Plastic Surgery
12.4.5. Wound Healing
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Biomaterial Market Size and Volume Forecast by Type
12.7.1. Metals and Metal Alloys
12.7.2. Synthetic Polymers
12.7.3. Ceramics
12.7.4. Natural Biomaterials
12.7.5. Composites
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Biomaterial Demand Share, 2019-2029
13. Middle East & Africa Implantable Biomaterial Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Biomaterial Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Biomaterial Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Orthopedic Application
13.4.3. Dental
13.4.4. Plastic Surgery
13.4.5. Wound Healing
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Biomaterial Market Size and Volume Forecast by Type
13.7.1. Metals and Metal Alloys
13.7.2. Synthetic Polymers
13.7.3. Ceramics
13.7.4. Natural Biomaterials
13.7.5. Composites
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Biomaterial Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Implantable Biomaterial Market: Market Share Analysis
14.2. Implantable Biomaterial Distributors and Customers
14.3. Implantable Biomaterial Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Carpenter Technology
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Collagen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Corbion
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Evonik Industries
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson Matthey
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Landec
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Materion
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Morgan Advanced Materials
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Royal Dsm Biomedical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Solvay
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Victrex
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
